Log In

Primary immunodeficiencies in the Netherlands: National patient data demonstrate the increased risk of malignancy

Files

immunodeficiencies.pdf (602.16 KB)
How and where to find an Open Access version of this publication?

Publication date

2015-02-01

Authors

Jonkman-Berk, B. M.
van den Berg, J. M.
ten Berge, I. J M
Bredius, R. G M
Driessen, G. J.
Dalm, V. A S H
van Dissel, J. T.
van Deuren, M.
Ellerbroek, P.M.ISNI 0000000392629991
Van der Flier, Michiel

Editors

Advisors

Supervisors

DOI

https://doi.org/10.1016/j.clim.2014.10.003

Document Type

Article

Metadata

Show full item record

Collections

UMC Repository

License

Abstract

Purpose: To analyze the data of the national registry of all Dutch primary immune deficiency (PID) patients, according to the European Society for Immunodeficiencies (ESID) definitions. Results: In the Netherlands, 745 patients had been registered between 2009 and 2012. An overall prevalence of 4.0 per 100,000 inhabitants was calculated. The most prevalent PID was 'predominantly antibody disorder (PAD)' (60.4%).In total, 118 transplantations were reported, mostly hematopoietic stem cell transplantations (HSCT). Almost 10% of the PID patients suffered from a malignancy, in particular 'lymphoma' and 'skin cancer'. Compared to the general Dutch population, the relative risk of developing any malignancy was 2.3-fold increased, with a >. 10-fold increase for some solid tumors (thymus, endocrine organs) and hematological disease (lymphoma, leukemia), varying per disease category. Conclusions: The incidence rate and characteristics of PID in the Netherlands are similar to those in other European countries. Compared to the general population, PID patients carry an increased risk to develop a malignancy.

Keywords

Infection, Malignancy, Primary immunodeficiencies, Transplantation, Immunology, Immunology and Allergy, General Medicine, Journal Article

Citation

Jonkman-Berk, B M, van den Berg, J M, ten Berge, I J M, Bredius, R G M, Driessen, G J, Dalm, V A S H, van Dissel, J T, van Deuren, M, Ellerbroek, P M, van der Flier, M, van Hagen, P M, van Montfrans, J M, Rutgers, A, Schölvinck, E H, de Vries, E, van Beem, R T & Kuijpers, T W 2015, 'Primary immunodeficiencies in the Netherlands : National patient data demonstrate the increased risk of malignancy', Clinical Immunology, vol. 156, no. 2, pp. 154-162. https://doi.org/10.1016/j.clim.2014.10.003

URI

http://hdl.handle.net/1874/331669